Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |